Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
J Clin Immunol ; 32(6): 1404-8, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22843217

ABSTRACT

Helicobacter bilis, an unusual cause of chronic infections in patients with X-linked agammaglobulinemia (XLA), is notoriously difficult to diagnose and eradicate. Based on the limited number of cases reported worldwide, we highlight the typical features of H. bilis infection in XLA and provide a rational and successful approach to diagnosis and treatment of this challenging infection.


Subject(s)
Agammaglobulinemia/drug therapy , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Genetic Diseases, X-Linked/drug therapy , Helicobacter Infections/drug therapy , Helicobacter/drug effects , Ofloxacin/therapeutic use , beta-Lactams/therapeutic use , Adolescent , Adult , Agammaglobulinemia/complications , Agammaglobulinemia/diagnosis , Agammaglobulinemia/pathology , Chronic Disease , Ertapenem , Genetic Diseases, X-Linked/complications , Genetic Diseases, X-Linked/diagnosis , Genetic Diseases, X-Linked/pathology , Helicobacter/genetics , Helicobacter/pathogenicity , Helicobacter Infections/complications , Helicobacter Infections/diagnosis , Helicobacter Infections/pathology , Humans , Male , Phylogeny , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...